Allergan (AGN) Presents Positive Data on Glaucoma Candidate

Allergan PLC AGN announced positive top-line results from a phase III study, evaluating its pipeline candidate Bimatoprost SR. Bimatoprost SR is Allergan’s investigational implant, developed as the first sustained-release drop-free treatment option for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.